Charlotte E. Ariyan, MD, PhD

Associate Attending, Gastric & Mixed Tumor Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Charlotte Eielson Ariyan is a board-certified general surgeon specializing in surgical oncology with a clinical expertise in melanoma and soft tissue sarcoma.
In her research, Dr. Ariyan investigates new ways to allow the immune system to fight cancer, through combinations of local treatments. She is also involved in the study of rare melanoma subtypes such as acral and mucosal melanoma.

Presentation(s):

• Stage IV (Timing/PT Selection, Are We Actually Operating More Frequently?)

  Thursday, March 23, 2023
  9:31 AM – 9:45 AM

  Disclosure(s): Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)

• Questions and Discussion

  Thursday, March 23, 2023
  9:45 AM – 10:00 AM

  Disclosure(s): Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)

• PeerView Independent Satellite Symposium: Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies

  Thursday, March 23, 2023
  7:00 PM – 8:30 PM

  Disclosure(s): Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)

• 74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma

  Friday, March 24, 2023
  1:01 PM – 1:13 PM

  Disclosure(s): Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)